U73122 ({1-[6-((17 beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)exyl]-1H-pyrrole-2,5-dione}) is generally used as a selective inhibitor of phospholipase C (PLC) and the related rise in cytosolic Ca2+. Recently, by using hepatocytes, it was suggested that its action sites are different for PLC activation and increase in Ca2+ concentration. To verify whether U73122 has different sites for inhibiting PLC activation and calcium responses in human platelets, aggregation, Mn2+ influx, cytosolic Ca2+ increase and PLC activation were studied in response to thrombin and the synthetic agonist of the thromboxane receptor U46619 (9,11-dideoxy-9 alpha,11 alpha-methanoepoxyprostaglandin F-2 alpha). With both agonists, U73122 inhibited aggregation, Mn2+ influx and the enhancement of cytosolic calcium at concentrations of 2 mu M or lower, while 10 mu M was necessary to inhibit PLC activation. Our results suggested that U73122 is much more active in antagonizing Ca2+ channels, both the intracellular ones, which are activated by formation of inositol 1,4,5 P-3 and those present on plasma membrane, than in reducing the activation of PLC. BIOCHEM PHARMACOL 56;11:1481-1484, 1998. (C) 1998 Elsevier Science Inc.

Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets / Pulcinelli, FABIO MARIA; Paolo, Gresele; Margherita, Bonuglia; Gazzaniga, Pierpaolo. - In: BIOCHEMICAL PHARMACOLOGY. - ISSN 0006-2952. - STAMPA. - 56:11(1998), pp. 1481-1484. [10.1016/s0006-2952(98)00146-4]

Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets

PULCINELLI, FABIO MARIA;GAZZANIGA, Pierpaolo
1998

Abstract

U73122 ({1-[6-((17 beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)exyl]-1H-pyrrole-2,5-dione}) is generally used as a selective inhibitor of phospholipase C (PLC) and the related rise in cytosolic Ca2+. Recently, by using hepatocytes, it was suggested that its action sites are different for PLC activation and increase in Ca2+ concentration. To verify whether U73122 has different sites for inhibiting PLC activation and calcium responses in human platelets, aggregation, Mn2+ influx, cytosolic Ca2+ increase and PLC activation were studied in response to thrombin and the synthetic agonist of the thromboxane receptor U46619 (9,11-dideoxy-9 alpha,11 alpha-methanoepoxyprostaglandin F-2 alpha). With both agonists, U73122 inhibited aggregation, Mn2+ influx and the enhancement of cytosolic calcium at concentrations of 2 mu M or lower, while 10 mu M was necessary to inhibit PLC activation. Our results suggested that U73122 is much more active in antagonizing Ca2+ channels, both the intracellular ones, which are activated by formation of inositol 1,4,5 P-3 and those present on plasma membrane, than in reducing the activation of PLC. BIOCHEM PHARMACOL 56;11:1481-1484, 1998. (C) 1998 Elsevier Science Inc.
1998
calcium channels; calcium mobilization; phospholipase c; platelets
01 Pubblicazione su rivista::01a Articolo in rivista
Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets / Pulcinelli, FABIO MARIA; Paolo, Gresele; Margherita, Bonuglia; Gazzaniga, Pierpaolo. - In: BIOCHEMICAL PHARMACOLOGY. - ISSN 0006-2952. - STAMPA. - 56:11(1998), pp. 1481-1484. [10.1016/s0006-2952(98)00146-4]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/105768
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 41
social impact